Carbapenem-resistant Klebsiella pneumoniae in ICU-admitted COVID-19 patients: Keep an eye on the ball

J Glob Antimicrob Resist. 2020 Dec:23:398-400. doi: 10.1016/j.jgar.2020.11.004. Epub 2020 Nov 23.

Abstract

Here we report on seven intensive care unit (ICU) patients with coronavirus disease 2019 (COVID-19)-related acute respiratory distress syndrome (ARDS) who developed positive rectal swabs and invasive infections due to carbapenemase-producing Klebsiella pneumoniae (CP-Kp). Notwithstanding the infection prevention measures introduced during the COVID-19 pandemic and changes in the hospitalised population, attention to CP-Kp infections must remain high, especially in the critically ill setting.

Keywords: Antimicrobial resistance; COVID-19; Carbapenem-resistant Klebsiella pneumonia; Carbapenemase; Infection control; Superinfection.

MeSH terms

  • Adult
  • Aged
  • COVID-19 / diagnosis
  • COVID-19 / epidemiology
  • COVID-19 / microbiology*
  • COVID-19 / therapy
  • Carbapenem-Resistant Enterobacteriaceae / isolation & purification*
  • Coinfection / epidemiology
  • Critical Illness
  • Female
  • Humans
  • Intensive Care Units / statistics & numerical data
  • Italy / epidemiology
  • Klebsiella Infections / epidemiology
  • Klebsiella Infections / microbiology
  • Klebsiella Infections / therapy
  • Klebsiella Infections / virology*
  • Klebsiella pneumoniae / isolation & purification*
  • Male
  • Middle Aged
  • SARS-CoV-2 / isolation & purification